Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.5B |
| 2 |
Apple
AAPL
|
+$1.68B |
| 3 |
Tesla
TSLA
|
+$951M |
| 4 |
Johnson & Johnson
JNJ
|
+$750M |
| 5 |
UnitedHealth
UNH
|
+$703M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CTXS
Citrix Systems Inc
CTXS
|
+$913M |
| 2 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$257M |
| 3 |
NVIDIA
NVDA
|
+$225M |
| 4 |
Vertiv
VRT
|
+$164M |
| 5 |
JPMorgan Chase
JPM
|
+$161M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.48% |
| 2 | Healthcare | 7.36% |
| 3 | Financials | 6.5% |
| 4 | Consumer Discretionary | 5.35% |
| 5 | Industrials | 3.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2651
Scansource
SCSC
$1.17B
| $1.1M | ﹤0.01% |
37,732
+9,262
| +33% | +$275K |
|
|
BMAC
2652
DELISTED
Black Mountain Acquisition Corp.
BMAC
| $1.1M | ﹤0.01% |
107,981
| – | – |
|
2653
Bread Financial
BFH
$4.54B
| $1.1M | ﹤0.01% |
29,219
+23,896
| +449% | +$863K |
|
2654
Nu Skin
NUS
$253M
| $1.1M | ﹤0.01% |
26,083
+11,582
| +80% | +$446K |
|
2655
Quaker Houghton
KWR
$2.94B
| $1.1M | ﹤0.01% |
6,587
+3,032
| +85% | +$510K |
|
2656
Nurix Therapeutics
NRIX
$2.61B
| $1.09M | ﹤0.01% |
99,657
+15,166
| +18% | +$183K |
|
2657
Enpro
NPO
$6.94B
| $1.09M | ﹤0.01% |
10,065
+4,673
| +87% | +$505K |
|
2658
ESCO Technologies
ESE
$8.49B
| $1.09M | ﹤0.01% |
12,481
+5,652
| +83% | +$487K |
|
2659
CALL
BHP
BHP
$227B
| $1.09M | ﹤0.01% |
+17,600
| New | +$990K |
|
|
CERO
2660
DELISTED
CERo Therapeutics
CERO
| $1.09M | ﹤0.01% |
53
| – | – |
|
2661
CALL
State Street Health Care Select Sector SPDR ETF
XLV
$42.3B
| $1.09M | ﹤0.01% |
+8,000
| New | +$1.06M |
|
2662
Astec Industries
ASTE
$1.04B
| $1.09M | ﹤0.01% |
26,728
+4,427
| +20% | +$179K |
|
|
FTCH
2663
DELISTED
Farfetch Limited Class A Ordinary Shares
FTCH
| $1.09M | ﹤0.01% |
229,636
-362,106
| -61% | -$2.52M |
|
2664
SSR Mining
SSRM
$6.02B
| $1.08M | ﹤0.01% |
69,180
-39,938
| -37% | -$585K |
|
2665
nCino
NCNO
$2.11B
| $1.08M | ﹤0.01% |
40,965
+35,409
| +637% | +$997K |
|
2666
NETSCOUT
NTCT
$2.98B
| $1.08M | ﹤0.01% |
33,309
+2,917
| +10% | +$101K |
|
2667
White Mountains Insurance
WTM
$5.23B
| $1.08M | ﹤0.01% |
762
-3,076
| -80% | -$4.17M |
|
2668
Westamerica Bancorp
WABC
$1.38B
| $1.08M | ﹤0.01% |
18,262
+9,041
| +98% | +$531K |
|
2669
Urban Outfitters
URBN
$6.67B
| $1.07M | ﹤0.01% |
45,051
-31,735
| -41% | -$790K |
|
2670
Univest Financial
UVSP
$1.22B
| $1.07M | ﹤0.01% |
41,012
+8,231
| +25% | +$221K |
|
2671
FS Bancorp
FSBW
$323M
| $1.07M | ﹤0.01% |
31,898
-455
| -1% | -$14.2K |
|
2672
Noble Corp
NE
$6.37B
| $1.07M | ﹤0.01% |
28,272
+23,097
| +446% | +$821K |
|
2673
GameStop
GME
$8.53B
| $1.06M | ﹤0.01% |
57,656
-20,083
| -26% | -$493K |
|
|
CVSA
2674
Covista Inc
CVSA
$4.39B
| $1.06M | ﹤0.01% |
29,980
+17,221
| +135% | +$672K |
|
2675
Dorman Products
DORM
$4.23B
| $1.06M | ﹤0.01% |
13,159
+5,701
| +76% | +$484K |
|
Similar funds
Barclays's Q4 2022 Portfolio in Review
As of Q4 2022, Barclays held 5,646 positions worth $223B, up 144% from $91.6B the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Barclays deployed $128B of net new capital in Q4 2022, opening 798 new positions and adding to 2,634 existing holdings. Its largest new stake was Seadrill: 1,546,558 shares worth $50.5M.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $257M trimmed.
- Barclays's largest Q4 2022 buy was Seadrill: 1,546,558 shares worth $50.5M.
- Barclays added most to Microsoft in Q4 2022, an estimated $2.5B increase.
- Barclays's biggest Q4 2022 reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, cutting an estimated $257M.
- Barclays fully exited Citrix Systems Inc in Q4 2022, selling an estimated $913M.
- Barclays's ten largest holdings make up 41% of its $223B portfolio in Q4 2022.
- Barclays opened 798 new positions and closed 385 in Q4 2022.
- Barclays's portfolio value rose 144% quarter-over-quarter to $223B.
Based on Barclays's 13F filing for Q4 2022, filed 13 Feb 2023.